Fatty Acids and Immune Function: Relevance to Inflammatory Bowel Diseases

REFERENCES

• P.C. Calder and G.C. Burdge. Fatty acids. In A. Nicolaou, and G. Kokotos, ( Eds.). Bioactive Lipids. Bridgewater, England: The Oily Press, pp. 1–36, 2004.
   Google Scholar
• P.C. Calder, J.A. Bond, D.J. Harvey, . Uptake and incorporation of saturated and unsaturated fatty acids into macrophage lipids and their effect upon macrophage adhesion and phagocytosis. Biochem J 269: 807–814, 1990.
   PubMed Web of Science ®Google Scholar
• P.C. Calder, P. Yaqoob, D.J. Harvey, . The incorporation of fatty acids by lymphocytes and the effect on fatty acid composition and membrane fluidity. Biochem J 300: 509–518, 1994.
   PubMed Web of Science ®Google Scholar
• P. Yaqoob, E.A. Newsholme, and P.C. Calder. Influence of cell culture conditions on diet-induced changes in lymphocyte fatty acid composition. Biochim Biophys Acta 1255: 333–340, 1995.
   PubMed Web of Science ®Google Scholar
• L.D. Peterson, N.M. Jeffery, F. Thies, . Eicosapentaenoic and docosahexaenoic acids alter rat spleen leukocyte fatty acid composition and prostaglandin E2 production but have different effects on lymphocyte functions and cell-mediated immunity. Lipids 33: 171–180, 1998.
   PubMed Web of Science ®Google Scholar
• F.A. Wallace, S.J. Neely, E.A. Miles, and P.C. Calder. Dietary fats affect macrophage-mediated cytotoxicity towards tumour cells. Immunol Cell Biol 78: 40–48, 2000.
   PubMed Web of Science ®Google Scholar
• F.A. Wallace, E.A. Miles, C. Evans, . Dietary fatty acids influence the production of Th1- but not Th2-type cytokines. J Leuk Biol 69: 449–457, 2001.
   PubMed Web of Science ®Google Scholar
• S. Kew, S. Wells, F. Thies, . The effect of eicosapentaenoic acid on rat lymphocyte proliferation depends upon its position in dietary triacylglycerols. J Nutr 133: 4230–4238, 2003.
   PubMed Web of Science ®Google Scholar
• K. Fritsche. Important differences exist in the dose-response relationship between diet and immune cell fatty acids in humans and rodents. Lipids 42: 961–979, 2007.
   PubMed Web of Science ®Google Scholar
• T.H. Lee, R.L. Hoover, J.D. Williams, . Effects of dietary enrichment with eicosapentaenoic acid and docosahexaenoic acid on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Eng J Med 312: 1217–1224, 1985.
   PubMed Web of Science ®Google Scholar
• S. Endres, R. Ghorbani, V.E. Kelley, . The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Eng J Med 320: 265–271, 1989.
   PubMed Web of Science ®Google Scholar
• R.I. Sperling, A.I. Benincaso, C.T. Knoell, . Dietary ω-3 polyunsaturated fatty acids inhibit phosphoinositide formation and chemotaxis in neutrophils. J Clin Invest 91: 651–660, 1993.
   PubMed Web of Science ®Google Scholar
• M.J. Gibney and B. Hunter. The effects of short- and long-term supplementation with fish oil on the incorporation of n-3 polyunsaturated fatty acids into cells of the immune system in healthy volunteers. Eur J Clin Nutr 47: 255–259, 1993.
   PubMed Web of Science ®Google Scholar
• G.E. Caughey, E. Mantzioris, R.A. Gibson, . The effect on human tumor necrosis factor α and interleukin 1β production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 63: 116–122, 1996.
   PubMed Web of Science ®Google Scholar
• P. Yaqoob, H.S. Pala, M. Cortina-Borja, . Encapsulated fish oil enriched in α-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions. Eur J Clin Invest 30: 260–274, 2000.
   PubMed Web of Science ®Google Scholar
• D.A. Healy, F.A. Wallace, E.A. Miles, . The effect of low to moderate amounts of dietary fish oil on neutrophil lipid composition and function. Lipids 35: 763–768, 2000.
   PubMed Web of Science ®Google Scholar
• F. Thies, G. Nebe-von-Caron, J.R. Powell, . Dietary supplementation with γ-linolenic acid or fish oil decreases T lymphocyte proliferation in healthy older humans. J Nutr 131: 1918–1927, 2001.
   PubMed Web of Science ®Google Scholar
• S. Kew, T. Banerjee, A.M. Minihane, . Relation between the fatty acid composition of peripheral blood mononuclear cells and measures of immune cell function in healthy, free-living subjects aged 25–72 y. Am J Clin Nutr 77: 1278–1286, 2003.
   PubMed Web of Science ®Google Scholar
• E.A. Miles, T. Banerjee, and P.C. Calder. The influence of different combinations of gamma-linolenic, stearidonic, and eicosapentaenoic acids on the fatty acid composition of blood lipids and mononuclear cells in human volunteers. Prost Leuk Essent Fatty Acids 70: 529–538, 2004.
   PubMed Web of Science ®Google Scholar
• S. Kew, M.D. Mesa, S. Tricon, . Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on immune cell composition and function in healthy humans. Am J Clin Nutr 79: 674–681, 2004.
   PubMed Web of Science ®Google Scholar
• D. Rees, E.A. Miles, T. Banerjee, . Dose-related effects of eicosapentaenoic acid on innate immune function in healthy humans: A comparison of young and older men. Am J Clin Nutr 83: 331–342, 2006.
   PubMed Web of Science ®Google Scholar
• D.S. Kelley, G.J. Nelson, J.E. Love, . Dietary alpha-linolenic acid alters tissue fatty acid composition, but not blood lipids, lipoproteins, or coagulation status in humans. Lipids 28: 533–537, 1993.
   PubMed Web of Science ®Google Scholar
• S. Kew, T. Banerjee, A.M. Minihane, . Lack of effect of foods enriched with plant- or marine-derived n-3 fatty acids on human immune function. Am J Clin Nutr 77: 1287–1295, 2003.
   PubMed Web of Science ®Google Scholar
• E. Mantzioris, M.J. James, R.A. Gibson, and L.G. Cleland. Dietary substitution with an alpha-linolenic acid-rich vegetable oil increases eicosapentaenoic acid concentrations in tissues. Am J Clin Nutr 59: 1304–1309, 1994.
   PubMed Web of Science ®Google Scholar
• R.A. Lewis, K.F. Austen, and R.J. Soberman. Leukotrienes and other products of the 5-lipoxygenase pathway: Biochemistry and relation to pathobiology in human diseases. N Eng J Med 323: 645–655, 1990.
   PubMed Web of Science ®Google Scholar
• S.L. Tilley, T.M. Coffman, and B.H. Koller. Mixed messages: Modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest 108: 15–23, 20001.
   Web of Science ®Google Scholar
• I. Hirata, M. Murano, M. Nitta, . Estimation of mucosal inflammatory mediators in rat DSS-induced colitis—Possible role of PGE2 in protection against mucosal damage. Digestion 63(Suppl. 1): 73–80, 2001.
   PubMedGoogle Scholar
• N. Nieto, M.I. Torres, A. Rios, and A. Gil. Dietary polyunsaturated fatty acids improve histological and biochemical alterations in rats with experimental ulcerative colitis. J Nutr 132: 11–19, 2002.
   PubMed Web of Science ®Google Scholar
• P. Sharon and W.F. Stenson. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 86: 453–460, 1984.
   PubMed Web of Science ®Google Scholar
• L.R. Empey, L.D. Jewell, M.L. Garg, . Indomethacin worsens and a leukotriene biosynthesis inhibitor accelerates mucosal healing in rat colitis. Can J Physiol Pharm 69: 480–487, 1991.
   PubMed Web of Science ®Google Scholar
• B.D. Levy, C.B. Clish, B. Schmidt, . Lipid mediator class switching during acute inflammation: Signals in resolution. Nature Immunol 2: 612–619, 2001.
   PubMed Web of Science ®Google Scholar
• I. Vachier, P. Chanez, C. Bonnans, . Endogenous anti-inflammatory mediators from arachidonate in human neutrophils. Biochem Biophys Res Commun 290: 219–224, 2002.
   PubMed Web of Science ®Google Scholar
• C.N. Serhan, A. Jain, S. Marleau, . Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol 171: 6856–6865, 2003.
   PubMed Web of Science ®Google Scholar
• A.T. Gewirtz, L.S. Collier-Hyams, A.N. Young, . Lipoxin A4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis. J Immunol 168: 5260–5267, 2002.
   PubMed Web of Science ®Google Scholar
• P. Yaqoob and P.C. Calder. Effects of dietary lipid manipulation upon inflammatory mediator production by murine macrophages. Cell Immunol 163: 120–128, 1995.
   PubMed Web of Science ®Google Scholar
• R.S. Chapkin, C.C. Akoh, and C.C. Miller. Influence of dietary n-3 fatty acids on macrophage glycerophospholipid molecular species and peptidoleukotriene synthesis. J Lipid Res 32: 1205–1213, 1991.
   PubMed Web of Science ®Google Scholar
• D.S. Kelley, P.C. Taylor, G.J. Nelson, and B.E. Mackey. Arachidonic acid supplementation enhances synthesis of eicosanoids without suppressing immune functions in young healthy men. Lipids 33: 125–130, 1998.
   PubMed Web of Science ®Google Scholar
• S.N. Meydani, S. Endres, M.M. Woods, . Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: Comparison between young and older women. J Nutr 121: 547–555, 1991.
   PubMed Web of Science ®Google Scholar
• C. Von Schacky, R. Kiefl, E. Jendraschak, and W.E. Kaminski. N-3 fatty acids and cysteinyl-leukotriene formation in humans in vitro, ex vivo, and in vivo. J Lab Clin Med 121: 302–309, 1993.
   PubMed Web of Science ®Google Scholar
• D.S. Kelley, P.C. Taylor, G.J. Nelson, . Docosahexaenoic acid ingestion inhibits natural killer cell activity and production of inflammatory mediators in young healthy men. Lipids 34: 317–324, 1999.
   PubMed Web of Science ®Google Scholar
• P. Wachtler, W. Konig, M. Senkal, . Influence of a total parenteral nutrition enriched with ω-3 fatty acids on leukotriene synthesis of peripheral leukocytes and systemic cytokine levels in patients with major surgery. J Trauma 42: 191–198, 1997.
   PubMedGoogle Scholar
• K. Mayer, C. Fegbeutel, K. Hattar, . Omega-3 vs. omega-6 lipid emulsions exert differential influence on neutrophils in septic shock patients: Impact on plasma fatty acids and lipid mediator generation. Intens Care Med 29: 1472–1481, 2003.
   PubMed Web of Science ®Google Scholar
• H. Grimm, N. Mertes, C. Goeters, . Improved fatty acid and leukotriene pattern with a novel lipid emulsion in surgical patients. Eur J Nutr 45: 55–60, 2006.
   PubMed Web of Science ®Google Scholar
• C.A. Hudert, K.H. Weylandt, Y. Lu, . Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proc Natl Acad Sci U S A 103: 11276–11281, 2006.
   PubMed Web of Science ®Google Scholar
• D.W. Goldman, W.C. Pickett, and E.J. Goetzl. Human neutrophil chemotactic and degranulating activities of leukotriene B5 (LTB5) derived from eicosapentaenoic acid. Biochem Biophys Res Commun 117: 282–288, 1983.
   PubMed Web of Science ®Google Scholar
• T.H. Lee, J.M. Mencia-Huerta, C. Shih, . Characterization and biologic properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene-B5 and the double lipoxygenase product. J Biol Chem 259: 2383–2389, 1984.
   PubMed Web of Science ®Google Scholar
• D. Bagga, L. Wang, R. Farias-Eisner, . Differential effects of prostaglandin derived from ω-6 and ω-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci U S A 100: 1751–1756, 2003.
   PubMed Web of Science ®Google Scholar
• M.M.B.W. Dooper, L. Wassink, L. M'Rabet, and Y.M.F. Graus. The modulatory effects of prostaglandin-E on cytokine production by human peripheral blood mononuclear cells are independent of the prostaglandin subtype. Immunology 107: 152–159, 2002.
   PubMed Web of Science ®Google Scholar
• E.A. Miles, E. Allen, and P.C. Calder. In vitro effects of eicosanoids derived from different 20-carbon fatty acids on production of monocyte-derived cytokines in human whole blood cultures. Cytokine 20: 215–223, 2002.
   PubMed Web of Science ®Google Scholar
• E.A. Miles, L. Aston, and P.C. Calder. In vitro effects of eicosanoids derived from different 20-carbon fatty acids on T helper type 1 and T helper type 2 cytokine production in human whole-blood cultures. Clin Exp Allergy 33: 624–632, 2003.
   PubMed Web of Science ®Google Scholar
• C.N. Serhan, C.B. Clish, J. Brannon, . Novel functional sets of lipid-derived mediators with antinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 192: 1197–1204, 2000.
   PubMed Web of Science ®Google Scholar
• C.N. Serhan, S. Hong, K. Gronert, . Resolvins: A family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter pro-inflammation signals. J Exp Med 196: 1025–1037, 2000.
   Web of Science ®Google Scholar
• M. Arita, M. Yoshida, S. Hong, . Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc Natl Acad Sci U S A 102: 7671–7676, 2005.
   PubMed Web of Science ®Google Scholar
• S. Hong, K. Gronert, P. Devchand, . Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood and glial cells: Autocoids in anti-inflammation. J Biol Chem 278: 14677–14687, 2003.
   PubMed Web of Science ®Google Scholar
• E.B. Schmidt, J.O. Pedersen, S. Ekelund, . Cod liver oil inhibits neutrophil and monocyte chemotaxis in healthy males. Atherosclerosis 77: 53–57, 1989.
   PubMed Web of Science ®Google Scholar
• E.B. Schmidt, K. Varming, J.O. Perdersen, . Long term supplementation with n-3 fatty acids. ii. Effect on neutrophil and monocyte chemotaxis. Scand J Clin Lab Invest 52, 229–236, 1992.
   PubMed Web of Science ®Google Scholar
• R. Luostarinen, A. Siegbahn, and T. Saldeen. Effect of dietary fish oil supplemented with different doses of vitamin E on neutrophil chemotaxis in healthy volunteers. Nutr Res 12, 1419–1430, 1992.
   Web of Science ®Google Scholar
• E.B. Schmidt, J.O. Pedersen, K. Varming, . N-3 fatty acids and leukocyte chemotaxis: Effects in hyperlipidemia, and dose-response studies in healthy males. Arterioscler Thromb 11, 429–435, 1991.
   PubMedGoogle Scholar
• A. Kumar, Y. Takada, A.M. Boriek, and B.B. Aggarwal. Nuclear factor-kappaB: Its role in health and disease. J Mol Med 82: 434–448, 2004.
   PubMed Web of Science ®Google Scholar
• L.H. Sigal. Basic science for the clinician 39: NF-kappaB-function, activation, control, and consequences. J Clin Rheumatol 12: 207–211, 2006.
   PubMed Web of Science ®Google Scholar
• N.D. Perkins. Integrating cell-signalling pathways with NF-kappaB and Iκ K function. Nat Rev Mol Cell Biol 8: 49–62, 2007.
   PubMed Web of Science ®Google Scholar
• S.Z. Zhang, X.H. Zhao, and D.C. Zhang. Cellular and molecular immunopathogenesis of ulcerative colitis. Cell. Mol Immunol 3: 35–40, 2006.
   PubMed Web of Science ®Google Scholar
• C. Jobin and R.B. Sartor. NF-kappaB signaling proteins as therapeutic targets for inflammatory bowel diseases. Inflamm Bowel Dis 6: 206–213, 2000.
   PubMed Web of Science ®Google Scholar
• A.J. Schottelius and A.S. Baldwin, Jr. A role for transcription factor NF-kappa B in intestinal inflammation. Int J Colorectal Dis 14: 18–28, 1999.
   PubMed Web of Science ®Google Scholar
• A. Mansén, H. Guardiola-Diaz, J. Rafter, . Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa. Biochem Biophys Res Commun 222: 844–851, 1996.
   PubMed Web of Science ®Google Scholar
• P. Desreumaux, O. Ernst, K. Geboes, . Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology 117: 73–81, 1999.
   PubMed Web of Science ®Google Scholar
• P. Desreumaux, L. Dubuquoy, S. Nutten, . Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies. J Exp Med 193: 827–838, 2001.
   PubMed Web of Science ®Google Scholar
• C.G. Su, X. Wen, S.T. Bailey, . A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. J Clin Invest 104: 383–389, 1999.
   PubMed Web of Science ®Google Scholar
• L. Dubuquoy, C. Rousseaux, X. Thuru, . PPARgamma as a new therapeutic target in inflammatory bowel diseases. Gut 55: 1341–1349, 2006.
   PubMed Web of Science ®Google Scholar
• W. Van den Berghe, L. Vermeulen, P. Delerive, . A paradigm for gene regulation: Inflammation, NF-kappaB and PPAR. Adv Exp Med Biol 544: 181–196, 2003.
   PubMed Web of Science ®Google Scholar
• R. De Caterina, M.I. Cybulsky, S.K. Clinton, . The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb 14: 1829–1836, 1994.
   PubMed Web of Science ®Google Scholar
• B. Khalfoun, F. Thibault, H. Watier, . Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6. Adv Exp Biol Med 400: 589–597, 1997.
   Web of Science ®Google Scholar
• C.J. Lo, K.C. Chiu, M. Fu, . Fish oil decreases macrophage tumor necrosis factor gene transcription by altering the NF kappa B activity. J Surg Res 82: 216–221, 1999.
   PubMed Web of Science ®Google Scholar
• T.A. Babcock, T. Novak, E. Ong, . Modulation of lipopolysaccharide-stimulated macrophage tumor necrosis factor-α production by ω-3 fatty acid is associated with differential cyclooxygenase-2 protein expression and is independent of interleukin-10. J Surg Res 107: 135–139, 2002.
   PubMed Web of Science ®Google Scholar
• T.E. Novak, T.A. Babcock, D.H. Jho, . NF-kappa B inhibition by omega-3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription. Am J Physiol 284: L84–L89, 2003.
   PubMed Web of Science ®Google Scholar
• Y. Zhao, S. Joshi-Barve, S. Barve, and L.H. Chen. Eicosapentaenoic acid prevents LPS-induced TNF-alpha expression by preventing NF-kappaB activation. J Am Coll Nutr 23: 71–78, 2004.
   PubMed Web of Science ®Google Scholar
• C.J. Lo, K.C. Chiu, M.J. Fu, . Fish oil modulates macrophage P44/42 mitogen-activated protein kinase activity induced by lipopolysaccharide. J Parent Ent Nutr 24: 159–163, 2000.
   PubMed Web of Science ®Google Scholar
• S. Xi, D. Cohen, S. Barve, and L.H. Chen. Fish oil suppressed cytokines and nuclear factor kappaB induced by murine AIDS virus infection. Nutr Res 21: 865–878, 2001.
   Web of Science ®Google Scholar
• T. Billiar, P. Bankey, B. Svingen, . Fatty acid uptake and Kupffer Cell function: Fish oil alters eicosanoid and monokine production to endotoxin stimulation. Surgery 104: 343–349, 1988.
   PubMed Web of Science ®Google Scholar
• G. Renier, E. Skamene, J. de Sanctis, and D. Radzioch. Dietary n-3 polyunsaturated fatty acids prevent the development of atherosclerotic lesions in mice: Modulation of macrophage secretory activities. Arterioscler Thomb 13: 1515–1524, 1993.
   PubMed Web of Science ®Google Scholar
• S. Sadeghi, F.A. Wallace, and P.C. Calder. Dietary lipids modify the cytokine response to bacterial lipopolysaccharide in mice. Immunology 96: 404–410, 1999.
   PubMed Web of Science ®Google Scholar
• T. Trebble, N.K. Arden, M.A. Stroud, . Inhibition of tumour necrosis factor-α and interleukin-6 production by mononuclear cells following dietary fish-oil supplementation in healthy men and response to antioxidant co-supplementation. Brit J Nutr 90: 405–412, 2003.
   PubMed Web of Science ®Google Scholar
• F.A. Wallace, E.A. Miles, and P.C. Calder. Comparison of the effects of linseed oil and different doses of fish oil on mononuclear cell function in healthy human subjects. Brit J Nutr 89: 679–689, 2003.
   PubMed Web of Science ®Google Scholar
• P.C. Calder. N-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83: 1505S–1519S, 2006.
   PubMed Web of Science ®Google Scholar
• P.C. Calder, J.A. Bond, S.J. Bevan, . Effect of fatty acids on the proliferation of concanavalin A-stimulated rat lymph node lymphocytes. Int J Biochem 23: 579–588, 1991.
   PubMedGoogle Scholar
• P.C. Calder and E.A. Newsholme. Polyunsaturated fatty acids suppress human peripheral blood lymphocyte proliferation and interleukin-2 production. Clin Sci 82: 695–700, 1992.
   PubMed Web of Science ®Google Scholar
• P.C. Calder and E.A. Newsholme. Unsaturated fatty acids suppress interleukin-2 production and transferrin receptor expression by concanavalin A-stimulated rat lymphocytes. Mediat Inflamm 1: 107–115, 1992.
   PubMedGoogle Scholar
• P. Yaqoob, E.A. Newsholme, and P.C. Calder. The effect of dietary lipid manipulation on rat lymphocyte subsets and proliferation. Immunology 82: 603–610, 1994.
   PubMed Web of Science ®Google Scholar
• C.A. Jolly, Y.H. Jiang, R.S. Chapkin, and D.N. McMurray. Dietary (n-3) polyunsaturated fatty acids suppress murine lymphoproliferation, interleukin-2 secretion, and the formation of diacylglycerol and ceramide. J Nutr 127: 37–43, 1997.
   PubMed Web of Science ®Google Scholar
• L.D. Peterson, F. Thies, P. Sanderson, . Low levels of eicosapentaenoic and docosahexaenoic acids mimic the effects of fish oil upon rat lymphocytes. Life Sci 62: 2209–2217, 1998.
   PubMed Web of Science ®Google Scholar
• P.C. Calder, S.J. Bevan, and E.A. Newsholme. The inhibition of T-lymphocyte proliferation by fatty acids is via an eicosanoid-independent mechanism. Immunology 75: 108–115, 1992.
   PubMed Web of Science ®Google Scholar
• E.A. Miles and P.C. Calder. Modulation of immune function by dietary fatty acids. Proc Nutr Soc 57: 277–292, 1998.
   PubMed Web of Science ®Google Scholar
• T.M. Stulnig and M. Zeyda. Immunomodulation by polyunsaturated fatty acids: Impact on T-cell signaling. Lipids 39: 1171–1175, 2004.
   PubMed Web of Science ®Google Scholar
• M. Zeyda and T.M. Stulnig. Lipid Rafts & Co.: An integrated model of membrane organization in T cell activation. Prog Lipid Res 45: 187–202, 2006.
   PubMed Web of Science ®Google Scholar
• L.J. Pike. Lipid rafts: Bringing order to chaos. J Lipid Res 44: 655–667, 2003.
   PubMed Web of Science ®Google Scholar
• K. Simons and D. Toomre. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1: 31–41, 2000.
   PubMed Web of Science ®Google Scholar
• Y.U. Katagiri, N. Kiyokawa, and J. Fujimoto. A role for lipid rafts in immune cell signaling. Microbiol Immunol 45: 1–8, 2001.
   PubMed Web of Science ®Google Scholar
• T.M. Razzaq, P. Ozegbe, E.C. Jury, . Regulation of T-cell receptor signaling by membrane microdomains. Immunology 113: 413–426, 2004.
   PubMed Web of Science ®Google Scholar
• T. Harder. Lipid raft domains and protein networks in T-cell receptor signal transduction. Curr Opin Immunol 16: 353–359, 2004.
   PubMed Web of Science ®Google Scholar
• T. Stulnig, M. Berger, T. Sigmund, . Polyunsaturated fatty acids inhibit T cell signal transduction by modification of detergent-soluble membrane domains. J Cell Biol 143: 637–644, 1998.
   PubMed Web of Science ®Google Scholar
• T.M. Stulnig, J. Huber, N. Leitinger, . Polyunsaturated eicosapentaenoic acid displaces proteins from membrane rafts by altering raft lipid composition. J Biol Chem 276: 37335–37340, 2001.
   PubMed Web of Science ®Google Scholar
• Y.Y. Fan, D.N. McMurray, L.H. Ly, and R.S. Chapkin. Dietary n-3 polyunsaturated fatty acids remodel mouse T-cell lipid rafts. J Nutr 133: 1913–1920, 2003.
   PubMed Web of Science ®Google Scholar
• M. Zeyda, A.B. Szekeres, M.D. Saemann, . Suppression of T cell signaling by polyunsaturated fatty acids: Selectivity in inhibition of mitogen-activated protein kinase and nuclear factor activation. J Immunol 170: 6033–6039, 2003.
   PubMed Web of Science ®Google Scholar
• M. Zeyda, G. Staffler, V. Horejsi, and W. Waldhausl. LAT displacement from lipid rafts as a molecular mechanism for the inhibition of T cell signalling by polyunsaturated fatty acids. J Biol Chem 277: 28418–28423, 2002.
   PubMed Web of Science ®Google Scholar
• P. Sanderson and P.C. Calder. Dietary fish oil appears to prevent the activation of phospholipase C-γ in lymphocytes. Biochim Biophys Acta 1392: 300–308, 1998.
   PubMedGoogle Scholar
• Y.Y. Fan, L.H. Ly, R. Barhoumi, . Dietary docosahexaenoic acid suppresses T cell protein kinase Cθ lipid raft recruitment and IL-2 production. J Immunol 173: 6151–6160, 2004.
   PubMed Web of Science ®Google Scholar
• P.C. Calder. Polyunsaturated fatty acids alter the rules of engagement. Future Lipidol 2: 27–30, 2007.
   Web of Science ®Google Scholar
• P. Sanderson, G.G. MacPherson, C.H. Jenkins, and P.C. Calder. Dietary fish oil diminishes the antigen presentation activity of rat dendritic cells. J Leuk Biol 62: 771–777, 1997.
   PubMed Web of Science ®Google Scholar
• J. Vilaseca, A. Salas, F. Guarner, R. Rodriguez, M. Martinez, and J-R. Malagelada. Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis. Gut 31: 539–544, 1990.
   PubMed Web of Science ®Google Scholar
• L.R. Empey, K. Walker, and R.N. Fedorak. Fish oil-enriched diet is mucosal protective against acetic acid-induced colitis in rats. Can J Physiol Pharm 70: 660–668, 1992.
   PubMedGoogle Scholar
• R. Shoda, K. Matsueda, S. Yamato, and N. Umeda. Therapeutic efficacy of n-3 polyunsaturated fatty acid in experimental Crohn's disease. J Gastroenterol 30(Suppl. 80): 98–101, 1995.
   PubMedGoogle Scholar
• H. Yuceyar, O. Ozutemiz, A. Huseyinov, . Is administration of n-3 fatty acids by mucosal enema protective against trinitrobenzene-induced colitis in rats? Prost Leuk Essent Fatty Acids 61: 339–345, 1999.
   PubMed Web of Science ®Google Scholar
• A. Andoh, T. Tsujikawa, I. Ishizuka, . N-3 fatty acid-rich diet prevents early response of interleukin-6 elevation in trinitrobenzene sulfonic acid-induced enteritis. Int J Mol Med 12: 721–725, 2003.
   PubMed Web of Science ®Google Scholar
• R.S. Chapkin, L.A. Davidson, L. Ly, . Immunomodulatory effects of (n-3) fatty acids: Putative link to inflammation and colon cancer. J Nutr 137: 200S–204S, 2007.
   PubMed Web of Science ®Google Scholar
• R. Lorenz, P.C. Weber, P. Szimnau, . Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease—A randomized, placebo-controlled, double-blind cross-over trial. J Intern Med Suppl 731: 225–232, 1989.
   PubMedGoogle Scholar
• K. Hillier, R. Jewell, L. Dorrell, and C.L. Smith. Incorporation of fatty acids from fish oil and olive oil into colonic mucosal lipids and effects upon eicosanoid synthesis in inflammatory bowel disease. Gut 32: 1151–1155, 1991.
   PubMed Web of Science ®Google Scholar
• A. B. Hawthorne, T.K. Daneshmend, C.J. Hawkey, . Treatment of ulcerative colitis with fish oil supplementation: A prospective 12 month randomised controlled trial. Gut 33: 922–928, 1992.
   PubMed Web of Science ®Google Scholar
• T.B. McCall, D. O'Leary, J. Bloomfield, and C.A. O'Morain. Therapeutic potential of fish oil in the treatment of ulcerative colitis. Aliment Pharmacol Ther 3: 415–424, 1989.
   PubMed Web of Science ®Google Scholar
• T. Shimizu, T. Fujii, R. Suzuki, . Effects of highly purified eicosapentaenoic acid on erythrocyte fatty acid composition and leukocyte and colonic mucosa leukotriene B4 production in children with ulcerative colitis. Pediat Gastroenterol Nutr 37: 581–585, 2003.
   PubMed Web of Science ®Google Scholar
• W.F. Stenson, D. Cort, J. Rodgers, . Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med 116: 609–614, 1992.
   PubMed Web of Science ®Google Scholar
• T.M. Trebble, N.K. Arden, S.A. Wootton, . Fish oil and antioxidants alter the composition and function of circulating mononuclear cells in Crohn's disease. Am J Clin Nutr 80: 1137–1144, 2004.
   PubMed Web of Science ®Google Scholar
• P. Salomon, A.A. Kornbluth, and H.D. Janowitz. Treatment of ulcerative colitis with fish oil n-3-omega-fatty acid: An open trial. J Clin Gastroenterol 12: 157–161, 1990.
   PubMed Web of Science ®Google Scholar
• A. Aslan and G. Triadafilopoulos. Fish oil fatty acid supplementation in active ulcerative colitis: A double-blind, placebo-controlled, crossover study. Am J Gastroenterol 87: 432–437, 1992.
   PubMed Web of Science ®Google Scholar
• S.M. Greenfield, A.T. Green, J.P. Teare, . A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis. Aliment Pharmacol Ther 7: 159–166, 1993.
   PubMed Web of Science ®Google Scholar
• A. Belluzzi, C. Brignola, M. Campieri, . Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Eng J Med 334: 1557–1560, 1996.
   PubMed Web of Science ®Google Scholar
• K. Loeschke, B. Ueberschaer, A. Pietsch, . n-3 fatty acids only delay early relapse of ulcerative colitis in remission. Dig Dis Sci 41: 2087–2094, 1996.
   PubMed Web of Science ®Google Scholar
• H. Lorenz-Meyer, P. Bauer, C. Nicolay, . Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease: A randomized controlled multicenter trial. Scand J Gastroenterol 31: 778–785, 1996.
   PubMed Web of Science ®Google Scholar
• G. Mantzaris, E. Archavlis, C. Zografos, . A prospective, randomized, placebo-controlled study of fish oil in ulcerative colitis. Hellen J Gastroenterol 9: 138–141, 1996.
   Google Scholar
• Y.Z. Almallah, S. Richardson, T. O'Hanrahan, . Distal procto-colitis, natural cytotoxicity, and essential fatty acids. Am J Gastroenterol 93: 804–809, 1998.
   PubMed Web of Science ®Google Scholar
• Y.Z. Almallah, S.W. Ewen, A. El-Tahir, . Distal proctocolitis and n-3 polyunsaturated fatty acids (n-3 PUFAs): The mucosal effect in situ. J Clin Immunol 20: 68–76, 2000.
   PubMed Web of Science ®Google Scholar
• T. Varghese and D. Coomansingh. Clinical response of ulcerative colitis with dietary omega-3 fatty acids: A double-blind randomized study. Brit J Surg 87(Suppl. 1): 73, 2000.
   Google Scholar
• T.M. Trebble, M.A. Stroud, S.A. Wootton, . High dose fish oil and antioxidants in Crohn's disease and the response of bone turnover: A randomised controlled trial. Brit J Nutr 94: 253–261, 2005.
   PubMed Web of Science ®Google Scholar
• B.G. Feagan, W.J. Sandborn, U. Mittmann, . Omega-3 free fatty acids for the maintenance of remission in Crohn disease: The EPIC Randomized Controlled Trials. JAMA 299: 1690–1697, 2008.
   PubMed Web of Science ®Google Scholar
• J.B. Rodgers. N-3 fatty acids in the treatment of ulcerative colitis. In: J. M. Kremer (Ed.). Medicinal Fatty Acids in Inflammation. Basel, Switzerland: Birkhauser Verlag, pp. 103–109, 1998.
   Google Scholar
• A. Belluzzi. N-3 fatty acids for the treatment of inflammatory bowel diseases. Proc Nutr Soc 61: 391–395, 2002.
   PubMed Web of Science ®Google Scholar
• A. Belluzzi. Polyunsaturated fatty acids and inflammatory bowel disease. Am J Clin Nutr 71: 339S–342S, 2000.
   PubMed Web of Science ®Google Scholar
• J.E. Teitelbaum and W.A. Walker. Review: The role of omega 3 fatty acids in intestinal inflammation. J Nutr Biochem 12: 21–32, 2001.
   PubMed Web of Science ®Google Scholar
• S.C. Mills, A.C. Windsor, and S.C. Knight. The potential interactions between polyunsaturated fatty acids and colonic inflammatory processes. Clin Exp Immunol 142: 216–228, 2005.
   PubMed Web of Science ®Google Scholar
• C.H. MacLean, W.A. Mojica, S.C. Morton, . Effects of omega-3 fatty acids on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis, Evidence Report/Technical Assessment No. 89. AHRQ Publication No. 04-E012-2, Agency for Healthcare Research and Quality, Rockville, 2004.
   Google Scholar
• D. Turner, S.H. Zlotkin, P.S. Shah, and A.M. Griffiths. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 21: CD006320, 2009.
   Google Scholar
• D. Turner, A.H. Steinhart, and A.M. Griffiths. Omega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 18: CD006443, 2007.
   Google Scholar
• M. De Ley, R. de Vos, D.W. Hommes, and P. Stokkers. Fish oil for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 17: CD005986, 2007.
   Google Scholar